mesalamine has been researched along with Alopecia in 8 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Alopecia: Absence of hair from areas where it is normally present.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The prednisolone dose was reduced to 7." | 1.51 | Case report of patient with a Cronkhite-Canada syndrome: sustained remission after treatment with corticosteroids and mesalazine. ( Drebber, U; Kaufmann, T; Kütting, F; Mertens, J; Nierhoff, D; Schulte, S; Steffen, HM; Töx, U, 2019) |
| "Despite NUDT15 variants showing significant association with thiopurine-induced adverse events (AEs) in Asians, it remains unclear which variants of NUDT15 or whether additional genetic variants should be tested to predict AEs." | 1.48 | NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study. ( Andoh, A; Araki, H; Endo, K; Hanai, H; Hiraoka, S; Hisamatsu, T; Hokari, R; Ikeya, K; Ishiguro, Y; Kakuta, Y; Kawai, Y; Kinouchi, Y; Kobayashi, T; Masamune, A; Matsumoto, T; Miura, M; Mizuno, S; Moroi, R; Motoya, S; Naganuma, M; Nagasaki, M; Naito, T; Nakagawa, S; Nakagawa, T; Nakamura, S; Nakase, H; Nishida, A; Okamoto, D; Onodera, K; Sakuraba, H; Sasaki, M; Shiga, H; Shimosegawa, T; Shinozaki, M; Suzuki, Y; Takagawa, T; Takahara, M; Toyonaga, T; Yanai, S, 2018) |
| "To identify the frequency of hair loss among patients with inflammatory bowel disease (IBD) and associated clinical and disease related factors." | 1.42 | Frequency and associated factors of hair loss among patients with inflammatory bowel disease. ( Abraham, B; Hou, J; Sellin, J; Shah, R, 2015) |
| "These are so far the first two cases of hair loss in connection with Pentasa recorded by the Swiss Drug Monitoring Center." | 1.29 | [Diffuse alopecia as side effect of mesalazine therapy in Crohn's disease]. ( Netzer, P, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakuta, Y | 1 |
| Kawai, Y | 1 |
| Okamoto, D | 1 |
| Takagawa, T | 1 |
| Ikeya, K | 1 |
| Sakuraba, H | 1 |
| Nishida, A | 1 |
| Nakagawa, S | 1 |
| Miura, M | 1 |
| Toyonaga, T | 1 |
| Onodera, K | 1 |
| Shinozaki, M | 1 |
| Ishiguro, Y | 1 |
| Mizuno, S | 1 |
| Takahara, M | 1 |
| Yanai, S | 1 |
| Hokari, R | 1 |
| Nakagawa, T | 1 |
| Araki, H | 1 |
| Motoya, S | 1 |
| Naito, T | 1 |
| Moroi, R | 1 |
| Shiga, H | 1 |
| Endo, K | 1 |
| Kobayashi, T | 1 |
| Naganuma, M | 1 |
| Hiraoka, S | 1 |
| Matsumoto, T | 1 |
| Nakamura, S | 1 |
| Nakase, H | 1 |
| Hisamatsu, T | 1 |
| Sasaki, M | 1 |
| Hanai, H | 1 |
| Andoh, A | 1 |
| Nagasaki, M | 1 |
| Kinouchi, Y | 1 |
| Shimosegawa, T | 1 |
| Masamune, A | 1 |
| Suzuki, Y | 1 |
| Schulte, S | 1 |
| Kütting, F | 1 |
| Mertens, J | 1 |
| Kaufmann, T | 1 |
| Drebber, U | 1 |
| Nierhoff, D | 1 |
| Töx, U | 1 |
| Steffen, HM | 1 |
| Shah, R | 1 |
| Abraham, B | 1 |
| Hou, J | 1 |
| Sellin, J | 1 |
| Best, C | 1 |
| Sudel, B | 1 |
| Atienza Amores, MR | 1 |
| Martín-Garrido, I | 1 |
| García-Contreras, R | 1 |
| Varela Aguilar, JM | 1 |
| Netzer, P | 2 |
| Hadjigogos, K | 1 |
8 other studies available for mesalamine and Alopecia
| Article | Year |
|---|---|
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
Topics: Alopecia; Antibodies, Monoclonal; Azathioprine; Biomarkers, Pharmacological; Genetic Predisposition | 2018 |
Case report of patient with a Cronkhite-Canada syndrome: sustained remission after treatment with corticosteroids and mesalazine.
Topics: Aged; Alopecia; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Diarrhea; Drug Adm | 2019 |
Frequency and associated factors of hair loss among patients with inflammatory bowel disease.
Topics: Adult; Alopecia; Anti-Inflammatory Agents; Biological Products; Chi-Square Distribution; Cross-Secti | 2015 |
Bone marrow suppression in the setting of normal thiopurine methyltransferase phenotype testing.
Topics: Adolescent; Alopecia; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow; Crohn Disease; Drug Hype | 2010 |
[Alopecia as adverse reaction of mesalazine].
Topics: Aged; Alopecia; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Female; Humans; Mesalamine | 2009 |
[Diffuse alopecia as side effect of mesalazine therapy in Crohn's disease].
Topics: Adult; Alopecia; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Dose- | 1995 |
[Mesalazine].
Topics: Alopecia; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Mesa | 1996 |
Unusual side effects of mesalazine.
Topics: Adult; Alopecia; Aminosalicylic Acids; Female; Humans; Mesalamine; Proctitis | 1991 |